当前位置:首页 - 行情中心 - 赛托生物(300583) - 财务分析 - 现金流量表

赛托生物

(300583)

  

流通市值:22.34亿  总市值:22.76亿
流通股本:1.86亿   总股本:1.90亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金447,290,981.21180,522,770.84605,873,475.96472,826,121.15
  收到的税费返还225,694.7626,090.83,226,298.426,008,155.2
  收到其他与经营活动有关的现金34,940,047.3840,971,995.7870,173,853.0874,502,568.32
  经营活动现金流入小计482,456,723.35221,520,857.42679,273,627.46553,336,844.67
  购买商品、接受劳务支付的现金163,945,722.6288,893,572.56294,881,931.04280,228,955.55
  支付给职工以及为职工支付的现金63,168,850.9932,383,915.62113,107,757.4183,664,413.55
  支付的各项税费51,918,454.2624,094,918.4442,062,598.6423,869,256.74
  支付其他与经营活动有关的现金82,691,153.8545,401,470.6670,691,113.287,764,996.01
  经营活动现金流出小计361,724,181.72190,773,877.28520,743,400.29475,527,621.85
  经营活动产生的现金流量净额120,732,541.6330,746,980.14158,530,227.1777,809,222.82
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,743,996.28-4,130,021.224,130,021.22
  处置固定资产、无形资产和其他长期资产收回的现金净额489,000489,00041,62825,620
  收到的其他与投资活动有关的现金---6,366,953.59
  投资活动现金流入小计4,232,996.28489,0004,171,649.2210,522,594.81
  购建固定资产、无形资产和其他长期资产支付的现金35,409,594.3430,686,397.2779,651,345.4834,956,932.98
  投资支付的现金--3,000,0003,000,000
  支付其他与投资活动有关的现金1,347,515.53---
  投资活动现金流出小计36,757,109.8730,686,397.2782,651,345.4837,956,932.98
  投资活动产生的现金流量净额-32,524,113.59-30,197,397.27-78,479,696.26-27,434,338.17
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,000,000-
  其中:子公司吸收少数股东投资收到的现金--1,000,000-
  取得借款收到的现金353,733,769.7210,733,769.7763,051,730455,240,232.3
  收到其他与筹资活动有关的现金4,894,737.434,894,737.4336,000,00035,214,040
  筹资活动现金流入小计358,628,507.13215,628,507.13800,051,730490,454,272.3
  偿还债务支付的现金430,838,452.24237,165,876.55718,177,327.6464,940,712.77
  分配股利、利润或偿付利息支付的现金13,684,279.356,617,682.4927,764,900.5622,661,868.71
  支付其他与筹资活动有关的现金47,846,854.3517,471,027.7725,045,934.7824,425,250.26
  筹资活动现金流出小计492,369,585.94261,254,586.81770,988,162.94512,027,831.74
  筹资活动产生的现金流量净额-133,741,078.81-45,626,079.6829,063,567.06-21,573,559.44
四、汇率变动对现金及现金等价物的影响-25,718.75-1,083,969.1-1,332,678.06-1,001,376.16
五、现金及现金等价物净增加额-45,558,369.52-46,160,465.91107,781,419.9127,799,949.05
  加:期初现金及现金等价物余额263,271,140.93263,271,140.93155,489,721.02155,489,721.02
  期末现金及现金等价物余额217,712,771.41217,110,675.02263,271,140.93183,289,670.07
补充资料:
  净利润30,959,000.57--84,680,814.44-
  资产减值准备6,387,283.35-53,073,813.02-
  固定资产和投资性房地产折旧80,250,562.83-158,259,853.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧80,250,562.83-158,259,853.7-
  无形资产摊销3,650,010.84-7,246,546.37-
  长期待摊费用摊销62,214.24-817,992.37-
  处置固定资产、无形资产和其他长期资产的损失-217,907.39-824,300.99-
  固定资产报废损失--483,203.03-
  财务费用16,006,317.87-30,360,293.6-
  投资损失-3,287,943.26--6,489,808.78-
  递延所得税-655,658.86-2,420,180.05-
  其中:递延所得税资产减少-655,658.86-3,087,732.9-
    递延所得税负债增加---667,552.85-
  存货的减少2,864,202.98-132,777,479.74-
  经营性应收项目的减少-88,806,681.09--133,821,213.74-
  经营性应付项目的增加72,767,499.44--4,975,915.99-
  现金的期末余额217,712,771.41-263,271,140.93-
  减:现金的期初余额263,271,140.93-155,489,721.02-
  现金及现金等价物的净增加额-45,558,369.52-107,781,419.91-
公告日期2026-08-292026-04-282026-04-282025-10-29
审计意见(境内)标准无保留意见
TOP↑